Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2410265 | Vaccine | 2006 | 12 Pages |
Abstract
To develop a vaccine against hepatitis C virus, we synthesized four long peptides from nonstructural proteins NS3, NS4 and NS5B containing HLA-class I and class II epitopes mainly inducing responses in natural infection. In HLA-A2.1 transgenic mice, the four peptides primed higher CTL responses to 6:7 minimal HLA-A2 epitopes than those induced by the minimal epitopes. HLA-A2.1/HLA-DR1 transgenic mice immunized with one peptide, containing a class II epitope implicated in viral resolution, developed IFNγ-producing CD4+-T and CD8+-T cells. These peptides recalled HCV-specific IFNγ-producing cells from HCV-infected patients’ PBMC. This support the selection of these domains for inclusion in a vaccine formulation.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
A. Fournillier, P. Dupeyrot, P. Martin, P. Parroche, A. Pajot, L. Chatel, A. Fatmi, E. Gerossier, C. Bain, Y.C. Lone, C. Trépo, G. Inchauspé,